We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Vascular Endothelial Growth Factor and Ischemic Stroke Risk: A Mendelian Randomization Study

    Introduction

    Previous studies have reported controversial relationships between circulating vascular endothelial growth factors (VEGF) and ischemic...

    **ao Zhang, **nzhi Hu, ... Tao Wang in Neurology and Therapy
    Article Open access 15 April 2024
  2. Assessment of vascular endothelial growth factor a serum level in pediatric hemophilic arthropathy

    Background

    Children with hemophilia have serious, recurrent joint bleeding that causes disabilities. Regular factor VIII concentrate replacements have...

    Omar Ahmed M. N. Saboony, Mona Abdullah El Sebaie, ... Hossam Salaheldin Abdelmohsen Labib in Egyptian Rheumatology and Rehabilitation
    Article Open access 30 January 2023
  3. The relationship between vascular endothelial growth factor-A serum level and the severity of diabetic peripheral neuropathy

    Background and aims

    Diabetic peripheral neuropathy (DPN) is a common microvascular complication in type 2 diabetes mellitus (T2DM). The nerve fibers...

    Mai Hesham Badrah, Talaat Abdelfattah Abdelaaty, ... Amr Yosry El Feky in Egyptian Rheumatology and Rehabilitation
    Article Open access 21 December 2022
  4. Chronic sildenafil citrate use decreases retinal vascular endothelial growth factor expression in diabetic rats: a pilot study

    Background

    Sildenafil citrate (SC) attenuates endothelial dysfunction. However, its effects on diabetic retinopathy (DR), which is mainly a...

    Osama A. Sorour, Elsayed Nassar, ... Dina Tadros in International Journal of Retina and Vitreous
    Article Open access 17 July 2023
  5. Vascular Endothelial Growth Factor C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular Age-Related Macular Degeneration: A Narrative Review

    The development of treatments targeting the vascular endothelial growth factor (VEGF) signaling pathways have traditionally been firstly investigated...

    Ian M. Leitch, Michael Gerometta, ... Megan E. Baldwin in Ophthalmology and Therapy
    Article Open access 01 June 2024
  6. Cabozantinib and Axitinib After Vascular Endothelial Growth Factor Therapy in Patients with Advanced Renal Cell Carcinoma: A Retrospective Cohort Study from England

    Background and Objective

    The tyrosine kinase inhibitors cabozantinib and axitinib have been widely used in England to treat advanced renal cell...

    Janet Brown, Brooke Harrow, ... Andrew Protheroe in Drugs - Real World Outcomes
    Article Open access 24 January 2024
  7. Serum vascular endothelial growth factor associated with the progression of granulosa cell tumor: a report of two cases

    Background

    Granulosa cell tumors (GCTs) account for approximately 2% of ovarian malignancies and are considered a rare type of ovarian cancer. GCTs...

    Kazuki Takasaki, Takayuki Ichinose, ... Kazunori Nagasaka in Journal of Ovarian Research
    Article Open access 14 June 2023
  8. Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data Analysis

    Background

    Anti-vascular endothelial growth factor (anti-VEGF) therapy is commonly used intravitreally for diabetic proliferative retinopathy, but...

    Jonathan Y. M. Lai, David R. Riley, ... Uazman Alam in Diabetes Therapy
    Article Open access 24 February 2024
  9. Intravitreal anti-vascular endothelial growth factor injections in pregnancy and breastfeeding: a case series and systematic review of the literature

    Introduction

    Anti-vascular endothelial growth factor (anti-VEGF) agents may occasionally need to be considered for sight-threatening macular pathology...

    Ariel Yuhan Ong, Christine A. Kiire, ... Samantha R. de Silva in Eye
    Article Open access 18 November 2023
  10. Maternal Uterine Artery Adenoviral Vascular Endothelial Growth Factor (Ad.VEGF-A165) Gene Therapy Normalises Fetal Brain Growth and Microglial Activation in Nutrient Restricted Pregnant Guinea Pigs

    Fetal growth restriction (FGR) is associated with uteroplacental insufficiency, and neurodevelopmental and structural brain deficits in the infant....

    M. D. Hristova, T. Krishnan, ... O. R. Vaughan in Reproductive Sciences
    Article Open access 21 June 2024
  11. Vascular endothelial growth factor-A level in human breast milk after intravitreal injection of ranibizumab: a case report

    Background

    Ranibizumab is one of intravitreal anti-vascular endothelial growth factor agents. It is applied in the treatments of choroidal...

    Ying Huang, Rong Zhou, ... Bing Lin in International Breastfeeding Journal
    Article Open access 31 March 2022
  12. Ocular and systemic vascular endothelial growth factor ligand inhibitor use and nephrotoxicity: an update

    Tumor growth is intricately linked to the process of angiogenesis, with a key role played by vascular endothelial growth factor (VEGF) and its...

    Dharshan Rangaswamy, Shankar Prasad Nagaraju, ... Srinivas Vinayak Shenoy in International Urology and Nephrology
    Article Open access 18 March 2024
  13. Vitreoretinal Interface Changes After Anti-vascular Endothelial Growth Factor Treatment in Highly Myopic Eyes: A Real-World Study

    Introduction

    To investigate changes in the vitreoretinal interface after anti-vascular endothelial growth factor (anti-VEGF) treatment in highly...

    Mei-Chi Tsui, Yi-Ting Hsieh, ... Tzyy-Chang Ho in Ophthalmology and Therapy
    Article Open access 01 April 2023
  14. Posterior vitreous attachment as a risk factor for endophthalmitis following intravitreal antivascular endothelial growth factor injection

    Purpose

    To evaluate the importance of the status of posterior vitreous in eyes with endophthalmitis following intravitreal anti-vascular endothelial...

    Eyyup Karahan, Durgul Acan, Mine Koru Toprak in International Ophthalmology
    Article 15 May 2024
  15. Subthreshold micropulse laser combined with anti-vascular endothelial growth factor therapy for diabetic macular edema: a systematic review and meta-analysis

    Purpose

    To evaluate the effects of subthreshold micropulse laser (SML) in addition to anti-vascular endothelial growth factor (VEGF) therapy for...

    Hironori Hosoya, Takashi Ueta, ... Tomoyasu Shiraya in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article Open access 25 April 2024
  16. Publication trends of vascular endothelial growth factor (VEGF) and anti-VEGF treatment in neovascular age-related macular degeneration during 2001–2020: a 20-year bibliometric study

    Purpose

    This study sought to provide an overview of the current research and further analyze publication trends in the field of vascular endothelial...

    Jiali Wu, Yimin Wang, ... **aodong Sun in International Ophthalmology
    Article 29 June 2024
  17. Vascular endothelial growth factor and the risk of venous thromboembolism: a genetic correlation and two-sample Mendelian randomization study

    Background

    The relationship between vascular endothelial growth factor (VEGF) and the risk of venous thromboembolism (VTE) has always been one of the...

    Qiaoyun Zhang, **aoyu Zhang, ... Youxin Wang in Thrombosis Journal
    Article Open access 08 November 2022
  18. Correlation between vascular endothelial growth factor A gene polymorphisms and tendon and ligament injury risk: a systematic review and meta-analysis

    Background

    Relevant evidence suggests that angiogenic factors contribute significantly to fibril matrix reconstruction following physical injuries to...

    **-yong Li, Yun-lu Wang, ... Peng-fei Han in Journal of Orthopaedic Surgery and Research
    Article Open access 06 February 2024
Did you find what you were looking for? Share feedback.